Literature DB >> 6625701

Musculoskeletal disorders in patients with hyperlipidaemia.

G R Struthers, D L Scott, P A Bacon, K W Walton.   

Abstract

We have assessed the nature and significance of musculoskeletal disorders in 166 patients with the commonly encountered forms of hyperlipidaemia attending a lipid clinic. The incidence of musculoskeletal disorders was determined by questionnaire to the patients, inquiries to general practitioners, and a review of hospital records. To ensure the sensitivity of these methods a series of negatively responding cases were seen and examined; none had identifiable musculoskeletal disease. Eight males with type IV hyperlipidaemia had recurrent acute attacks of gout. The only other musculoskeletal disorder possibly attributable to an association with hyperlipidaemia was a transient polyarthritis in 3 patients. This was inflammatory, recurrent, but nondeforming, and involved the small joints of the hand. It did not require any specific therapy or lead to disability. We suggest that, while we have confirmed the association of type IV hyperlipidaemia and gout, there is little evidence for clinically significant arthritis being associated with other commonly presenting forms of hyperlipidaemia, although we accept that the rarely met homozygous familial hypercholesterolaemia may also be complicated by a crystal arthropathy due to the presence of crystalline cholesterol in joints.

Entities:  

Mesh:

Year:  1983        PMID: 6625701      PMCID: PMC1001287          DOI: 10.1136/ard.42.5.519

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  19 in total

1.  Polyarthritis associated with type IV hyperlipoproteinemia.

Authors:  R B Buckingham; G G Bole; D R Bassett
Journal:  Arch Intern Med       Date:  1975-02

2.  Gout and hyperlipidaemia.

Authors:  T Gibson; R Grahame
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

3.  Musculoskeletal disorders associated with type-IV hyperlipoproteinaemia.

Authors:  J A Goldman; C J Glueck; N R Abrams; P Steiner; J H Herman
Journal:  Lancet       Date:  1972-09-02       Impact factor: 79.321

4.  Observations concerning the incidence of disturbance of lipid and carbohydrate metabolism in gout.

Authors:  O Frank
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

5.  Plasma lipid levels in gout.

Authors:  L G Darlington; J T Scott
Journal:  Ann Rheum Dis       Date:  1972-11       Impact factor: 19.103

Review 6.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

7.  Acute tendinitis and arthritis. A presenting symptom of familial type II hyperlipoproteinemia.

Authors:  C J Glueck; R I Levy; D S Frederickson
Journal:  JAMA       Date:  1968-12-23       Impact factor: 56.272

8.  Hyperlipidemia in primary gout.

Authors:  K A Barlow
Journal:  Metabolism       Date:  1968-03       Impact factor: 8.694

9.  Correlations of serum uric acid and lipid concentrations in normal, gouty, and atherosclerotic men.

Authors:  T G Benedek
Journal:  Ann Intern Med       Date:  1967-05       Impact factor: 25.391

10.  Serum lipids, lipoproteins and musculoskeletal disorders among 50- and 60-year-old men. An epidemiologic study.

Authors:  L Welin; B Larsson; K Svärdsudd; G Tibblin
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

View more
  6 in total

1.  An unusual crystal.

Authors:  W Watson Buchanan; Walter F Kean
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

2.  Serum lipid profile in fibromyalgia women.

Authors:  Gulcan Gurer; Omer Faruk Sendur; Cavidan Ay
Journal:  Clin Rheumatol       Date:  2005-10-01       Impact factor: 2.980

3.  Hyperlipidemias and rheumatic manifestations.

Authors:  B Fishel; T O Rosenbach; M Yaron; A Rubinstein
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

4.  Musculoskeletal manifestations in hyperlipidaemia: a controlled study.

Authors:  P Klemp; A M Halland; F L Majoos; K Steyn
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

5.  Increase of circulating CD11b(+)Gr1(+) cells and recruitment into the synovium in osteoarthritic mice with hyperlipidemia.

Authors:  Kentaro Uchida; Kouji Naruse; Masashi Satoh; Kenji Onuma; Masaki Ueno; Shotaro Takano; Ken Urabe; Masashi Takaso
Journal:  Exp Anim       Date:  2013

6.  LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study.

Authors:  Yune-Jung Park; Chul-Soo Cho; Paul Emery; Wan-Uk Kim
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.